We hope this email finds you well. In an effort to support the continued development of this work, we want to pass along any resources that may be useful. Please see the message below from one of our Phase 3 Principle Investigators, Scott Shannon, MD.
 
Business of Psychedelic Medicine Survey

Dear Colleague:
 
The rescheduling of MDMA and psilocybin has the potential to change the face of mental health care around the world. We are witnessing a massive surge in the interest and support for psychedelic medicine. This includes interest in training for mental health practitioners to provide this care. A number of psychedelic medicine supporters have concerns that the strong interest in psychedelic medicine training by psychotherapists and psychiatrists will not translate well into the business of setting up and running clinics for this type of care. We are concerned that the lack of business expertise will create a roadblock for this paradigm shift in mental health that may become a significant business opportunity as well.
 
As a result, we are considering whether to provide concise and practical trainings about how to set up and run a psychedelic medicine clinic. This training would help individuals without business or start up experience feel more comfortable about starting a new clinic with this specific focus. In collaboration with MAPS, we have attached a link to a brief (less than 5 minutes) survey to explore your views and interest in this topic. This training would be supported by philanthropy and run by our non-profit organization PRATI. This project is not being run by MAPS, so please do not reach out to them. If we decide to move forward I will be the point person. 
 
If you complete the survey we will send you a copy of our summary of the data we collected.
 
Survey link: https://forms.gle/RrZAKw2mveT9EFhZ8
 
I appreciate your participation.
 
Scott Shannon, MD FAACAP
Psychiatrist
Clinical Investigator (site Principal Investigator), Study Physician and Therapist: 
MAPS MDMA-Assisted Psychotherapy Research
Wholeness Center Research- Fort Collins, CO

Thank you!

MAPS Public Benefit Corp is still in the review process with the FDA for the Expanded Access protocol and the protocol is still pending approval. We will continue to provide updates on the MDMA Therapy Training Program and MAPS PBC protocols when they available. We appreciate your patience and continued support as we work to bring the healing potential of MDMA-Assisted Psychotherapy for PTSD to those in need.

Kind regards,

MDMA Therapy Training Program